Milder clinical presentation of haemophilia A with severe deficiency of factor VIII as measured by one-stage assay

被引:55
作者
Ghosh, K [1 ]
Shetty, S [1 ]
Mohanty, D [1 ]
机构
[1] KEM Hosp, Inst Immunohaematol, Parel 400012, Mumbai, India
关键词
milder presentation; one-stage assay; severe haemophilia; thrombohaemorrhagic balance; two-stage assay;
D O I
10.1046/j.1365-2516.2001.00455.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
During the course of investigations eye encountered 11 patients with haemophilia A who had severe factor VIII deficiency as measured by one-stage assay but had surprisingly mild clinical presentation. Four of these patients had either a brother, nephew or maternal uncle with severe clinical manifestations. Two patients had low protein S levels, and one was heterozygous for the factor V Leiden mutation. One patient had a combined deficiency of protein C and antithrombin III. Four patients had a two-stage factor VIII assay value that was much higher than the one-stage assay value. Five patients were heterozygous for the MTHFR gene C677T polymorphism, of whom two patients were also deficient for protein S and one had two-stage factor assay values higher than the one-stage assay values. The patient who was both factor VIII deficient and heterozygous for factor V Leiden had mild clinical presentation as compared to his maternal uncle who was only factor-VIII deficient. The maternal cousin of the same patient was heterozygous for factor V Leiden and had suffered two thrombotic episodes. Thus, the present study advocates that the physiological inhibitors of blood coagulation also play an important:role in cases of haemophilia A in the final outcome of haemostasis in vivo.
引用
收藏
页码:9 / 12
页数:4
相关论文
共 15 条
[1]  
Barrowcliffe T W, 1984, Scand J Haematol Suppl, V41, P39
[2]  
BARROWCLIFFE TW, 1983, THROMB HAEMOSTASIS, V50, P697
[3]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[4]   THE ASSAY OF ANTIHAEMOPHILIC-GLOBULIN ACTIVITY [J].
BIGGS, R ;
EVELING, J ;
RICHARDS, G .
BRITISH JOURNAL OF HAEMATOLOGY, 1955, 1 (01) :20-34
[5]  
BITHELL TC, 1993, WINTROBES CLIN HEMAT, V2, P1422
[6]   FAMILIAL DISCREPANCY BETWEEN THE ONE-STAGE AND 2-STAGE FACTOR-VIII METHODS IN A SUBGROUP OF PATIENTS WITH HEMOPHILIA-A [J].
DUNCAN, EM ;
DUNCAN, BM ;
TUNBRIDGE, LJ ;
LLOYD, JV .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (04) :846-848
[7]   A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE [J].
FROSST, P ;
BLOM, HJ ;
MILOS, R ;
GOYETTE, P ;
SHEPPARD, CA ;
MATTHEWS, RG ;
BOERS, GJH ;
DENHEIJER, M ;
KLUIJTMANS, LAJ ;
VANDENHEUVEL, LP ;
ROZEN, R .
NATURE GENETICS, 1995, 10 (01) :111-113
[8]  
HARDISTY RM, 1962, THROMB DIATH HAEMOST, V7, P215
[9]  
HATHAWAY WE, 1983, THROMB HAEMOSTASIS, V50, P357
[10]   Linkage of combined Factors V and VII deficiency to chromosome 18q by homozygosity mapping [J].
Nichols, WC ;
Seligsohn, U ;
Zivelin, A ;
Terry, VH ;
Arnold, ND ;
Siemieniak, DR ;
Kaufman, RJ ;
Ginsburg, D .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (04) :596-601